Compare GRFS & ORLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRFS | ORLA |
|---|---|---|
| Founded | 1940 | 2007 |
| Country | Spain | Canada |
| Employees | 25247 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 6.0B |
| IPO Year | N/A | 2016 |
| Metric | GRFS | ORLA |
|---|---|---|
| Price | $8.48 | $16.18 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $10.15 | ★ $21.00 |
| AVG Volume (30 Days) | 649.3K | ★ 2.3M |
| Earning Date | 07-28-2022 | 05-08-2026 |
| Dividend Yield | ★ 1.63% | 0.09% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.69 | $55.69 |
| Revenue Next Year | $6.49 | N/A |
| P/E Ratio | ★ $18.67 | $107.37 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.90 | $8.50 |
| 52 Week High | $11.14 | $21.98 |
| Indicator | GRFS | ORLA |
|---|---|---|
| Relative Strength Index (RSI) | 53.66 | 45.85 |
| Support Level | $8.27 | $9.76 |
| Resistance Level | $9.08 | $18.49 |
| Average True Range (ATR) | 0.21 | 1.02 |
| MACD | 0.09 | -0.02 |
| Stochastic Oscillator | 67.73 | 29.40 |
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
Orla Mining Ltd is a mineral exploration company. It is engaged in the acquisition and exploration of mineral properties. The company holds three gold projects: the Camino Rojo gold and silver project in Zacatecas State, the Musselwhite gold mine project located in Ontario and the South Railroad projects in Nevada, USA, and the Cerro Quema gold project in Panama. It conducts business activities in Mexico, Panama, the United States, and Canada.